logo

BON

Bon Natural Life·NASDAQ
--
--(--)
--
--(--)
4.99 / 10
Netural

Fundamentally, BON shows moderate health. The equity multiplier (1.45) and low long‑term debt‑to‑working‑capital (0.045) are strengths, while operating cash‑flow growth (100.9) and current ratio (1.74) are weak, yielding a neutral rating.

Fundamental(4.99)SentimentTechnical

Analysis Checks(3/5)

Net cash flow from operating activities per share (YoY growth rate %)
Value100.89
Score0/3
Weight-2.00%
1M Return-0.35%
Long-term debt to working capital ratio (%)
Value0.05
Score3/3
Weight44.42%
1M Return6.10%
Interest coverage ratio (EBIT / Interest expense) (%)
Value35.11
Score2/3
Weight18.61%
1M Return2.48%
Equity multiplier (DuPont analysis %)
Value1.45
Score2/3
Weight27.32%
1M Return3.76%
Current ratio
Value1.74
Score1/3
Weight11.65%
1M Return1.73%
Is BON fundamentally strong?
  • BON scores 4.99/10 on fundamentals and holds a Fair valuation at present. Backed by its -3.90% ROE, -10.98% net margin, -5.22 P/E ratio, 0.18 P/B ratio, and -117.27% earnings growth, these metrics solidify its Netural investment rating.